Some polymorphisms are involved in tauopathy but not β-amyloid [46], and an increased expression suggests an increased risk of memory impairment, which promotes disease progression by modulating tau pathogenesis in AD patients [45,46,47]. Here, MAPT is linked to Alzheimer disease.